Marc N. Hirt
Institute of Experimental Pharmacology and Toxicology
University Medical Center Hamburg-Eppendorf
Marc N. Hirt has not added Biography.
If you are Marc N. Hirt and would like to personalize this page please email our Author Liaison for assistance.
Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology.
PloS one , 2011 | Pubmed ID: 22028871
Increased afterload induces pathological cardiac hypertrophy: a new in vitro model.
Basic research in cardiology Nov, 2012 | Pubmed ID: 23099820
Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.
Journal of molecular and cellular cardiology Oct, 2013 | Pubmed ID: 23896226
Cardiac tissue engineering: state of the art.
Circulation research Jan, 2014 | Pubmed ID: 24436431
Automated analysis of contractile force and Ca2+ transients in engineered heart tissue.
American journal of physiology. Heart and circulatory physiology May, 2014 | Pubmed ID: 24585781
Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation.
Journal of molecular and cellular cardiology Sep, 2014 | Pubmed ID: 24852842
Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology.
Journal of molecular and cellular cardiology Apr, 2015 | Pubmed ID: 25633833
General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.
Clinical research in cardiology : official journal of the German Cardiac Society May, 2016 | Pubmed ID: 26552905
DNA methylation in an engineered heart tissue model of cardiac hypertrophy: common signatures and effects of DNA methylation inhibitors.
Basic research in cardiology Jan, 2016 | Pubmed ID: 26680771
Spontaneous Formation of Extensive Vessel-Like Structures in Murine Engineered Heart Tissue.
Tissue engineering. Part A Feb, 2016 | Pubmed ID: 26763667
Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue.
PloS one , 2016 | Pubmed ID: 26840448
Human Engineered Heart Tissue: Analysis of Contractile Force.
Stem cell reports Jul, 2016 | Pubmed ID: 27211213
Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.
Circulation Sep, 2016 | Pubmed ID: 27559042
Human iPSC-derived cardiomyocytes cultured in 3D engineered heart tissue show physiological upstroke velocity and sodium current density.
Scientific reports Jul, 2017 | Pubmed ID: 28710467
Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats.
Journal of molecular and cellular cardiology Jul, 2018 | Pubmed ID: 29792884
S100A4 as a Target of the E3-Ligase Asb2β and Its Effect on Engineered Heart Tissue.
Frontiers in physiology , 2018 | Pubmed ID: 30283351
Toward Second-Generation Cardiomyogenic and Anti-cardiofibrotic 1,4-Dihydropyridine-Class TGFβ Inhibitors.
ChemMedChem 04, 2019 | Pubmed ID: 30768867
Blockade of miR-140-3p prevents functional deterioration in afterload-enhanced engineered heart tissue.
Scientific reports 08, 2019 | Pubmed ID: 31391475
Long Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac Fibrosis.
Molecular therapy. Nucleic acids Dec, 2019 | Pubmed ID: 31634682
A magnetics-based approach for fine-tuning afterload in engineered heart tissues.
ACS biomaterials science & engineering Jul, 2019 | Pubmed ID: 31637285
Phosphomimetic cardiac myosin-binding protein C partially rescues a cardiomyopathy phenotype in murine engineered heart tissue.
Scientific reports Dec, 2019 | Pubmed ID: 31796859
Aging-regulated anti-apoptotic long non-coding RNA Sarrah augments recovery from acute myocardial infarction.
Nature communications Apr, 2020 | Pubmed ID: 32341350
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유